A new study in the December 15 issue of the Journal of Clinical Sleep Medicine suggests drugs and substances are frequently found among patients being evaluated for hypersomnia and if undetected, may confound the MSLT results and the physician’s diagnosis. According to the authors, the results of this study support routine drug testing of patients undergoing assessment for a central hypersomnia.
Patients undergoing MSLT should have urine drug testing
2016-11-23T00:00:00+00:00November 23rd, 2016|Research|
January 17th, 2019 | 0 Comments
December 28th, 2018 | 0 Comments
November 1st, 2018 | 0 Comments
June 22nd, 2018 | 0 Comments